SecBot SecBot

MBIO

MUSTANG BIO, INC.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001680048 Biotech & Drug Discovery
$0.3600 −0.01 (−2.70%)
Oct 26 4:00 PM ET · prev $0.3700
Market cap
$2.8M
Nano cap
Next earnings
Nov 5
in 9 days
1 year
−76.0%
from $1.50 · Oct 27
30 days
−29.0%
from $0.5070
52-week range
$0.3600–1.50
at the low
Avg volume 20D
40.7K
Oct 14 spike 159.8K
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 5, 2026
Strongest BEARISH Mustang Bio received Nasdaq notice that its stock failed to meet the $1.00 minimum bid price by the initial…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • TrendDOWNTREND

    26% below its 50-day average. New closing low $0.3600 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCTRIM42,240$29.7K
Kestra Advisory Services, LLCADD176,042$128.2K
GEODE CAPITAL MANAGEMENT, LLCDOUBLED92,790$67.5K
UBS Group AGDOUBLED3,659$2.7K
Kestra Advisory Services, LLCADD111,042$108.9K
MORGAN STANLEYTRIM153$150.00
BlackRock, Inc.DOUBLED84,745$128.8K
GEODE CAPITAL MANAGEMENT, LLCADD26,418$40.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2024
Recent actions
DateFirmActionRating
May 16, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
May 13, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Aug 24, 2023Cantor Fitzgerald
REITERATE
REITERATEOverweight
Aug 16, 2023HC Wainwright & Co.
REITERATE
REITERATEBuy
Aug 15, 2023BTIG
MAINTAIN
MAINTAINBuy
Aug 15, 2023HC Wainwright & Co.
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Apr 24, 2026
Litchman Manuel MD
President, CEO and Interim CFO
TAX W/H$14.25

Earnings setup

Estimates
Nov 5
reports in 9 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Mustang Bio received Nasdaq notice that its stock failed to meet the $1.00 minimum bid price by the initial 180-day…
8-K — Impact 6/10
Aug 6, 2026 Earnings calendar
MBIO Q2 2026 Earnings Scheduled — 2026-08-06
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
42,240 shares ($29.7K)
Apr 24, 2026 Insider
Litchman Manuel MD surrendered for taxes 19 shares
President, CEO and Interim CFO @ $0.7500 ($14.25)
Apr 17, 2026 SEC
Mustang Bio (MBIO) received a Nasdaq delisting notice due to its stock trading below $1.00 for 30 consecutive days…
8-K — Impact 8/10
Mar 31, 2026 Inst.
Kestra Advisory Services, LLC — ADD
176,042 shares ($128.2K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
MBIO Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Aug 6, 2026
Earnings date
MBIO Q2 2026 Earnings Scheduled — 2026-08-06
May 12, 2026
Earnings date
MBIO Q1 2026 Earnings Scheduled — 2026-05-12
Mar 26, 2026
Earnings date
MBIO Q4 2025 Earnings After Market Close — 2026-03-26

SecBot reports

2 filings · 0 bullish · 2 bearish
All MBIO filing & press-release reports (2)